Review of nano-based devices planned by EU committee

04/2/2012 | Clinica (subscription required)

The European Commission's Scientific Committee on Emerging and Newly Identified Health Risks has been asked to perform a risk evaluation of medical devices that use nanomaterials and submit feedback by next March. The commission will use the feedback to help craft proposals on labeling, risk categorization and instructions for these devices.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN